Bahamas
Tuberculosis profile
| High HIV burden |
Population  2013 <1 million
Estimates of TB burden * 2013 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) <0.01 (<0.01–<0.01) 0.48 (0.42–0.55)
Mortality (HIV+TB only) <0.01 (<0.01–<0.01) 0.53 (0.28–0.86)
Prevalence  (includes HIV+TB) 0.037 (0.017–0.064) 9.9 (4.6–17)
Incidence  (includes HIV+TB) 0.037 (0.035–0.04) 9.8 (9.3–11)
Incidence (HIV+TB only) 0.012 (0.011–0.014) 3.3 (3–3.8)
Case detection, all forms (%) 89 (83–94)    
Estimates of MDR-TB burden * 2013   New   Retreatment
% of TB cases with MDR-TB 3.7 (0.09–19) 0 (0–71)
MDR-TB cases among notified pulmonary
TB cases
1 (0–6) 0 (0–2)
TB case notifications 2013 New ** Relapse
Pulmonary, bacteriologically confirmed 26   3
Pulmonary, clinically diagnosed 4   0
Extrapulmonary 0   0
       
Total new and relapse 33    
Previously treated, excluding relapses 0    
Total cases notified 33    
Among 33 new and relapse cases:
3 (9%) cases aged under 15 years; male:female ratio: 2.0
Reported cases of RR-/MDR-TB 2013 New Retreatment Total **
Cases tested for RR-/MDR-TB 16 (62%) 3 (100%) 19
Laboratory-confirmed RR-/MDR-TB cases     2
Patients started on MDR-TB treatment     0
TB/HIV 2013 Number (%)
TB patients with known HIV status 33 (100)
HIV-positive TB patients 10 (30)
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT) 3 (30)
HIV-positive TB patients on antiretroviral therapy (ART) 5 (50)
HIV-positive people screened for TB    
HIV-positive people provided with IPT    
Treatment success rate (%)
New and relapse cases registered in 2012 84
Previously treated cases, excluding relapse, registered in 2012  
HIV-positive TB cases, all types, registered in 2012 75
RR-/MDR-TB cases started on second-line treatment in 2011 0
XDR-TB cases started on second-line treatment in 2011  
Laboratories 2013  
Is second-line drug susceptibility testing available? Yes, outside
country
Financing TB control 2014  
National TB programme budget (US$ millions) <1
* Ranges represent uncertainty intervals
** Includes cases with unknown previous TB treatment history
***
(Rate per 100 000 population per year)
Mortality graph
   Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
   Prevalence

(Rate per 100 000 population per year)
Incidence graph
   Notified (new and relapse)   Incidence
   Incidence (HIV+TB only)

(Number of patients)
CPT ART graph
   HIV-positive TB patients
   on CPT   on ART

Treatment success rate (%)
tx success graph
   New   Retreatment
   New and relapse   Retreatment, excluding
relapse
   HIV-positive   RR-/MDR-TB   XDR-TB

 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 Generated: 2015-08-03 Data: www.who.int/tb/data